Increased von Willebrand factor to ADAMTS13 ratio as a predictor of thrombotic complications following a major hepatectomy

Archives of Surgery

Volumn 147, Issue 10, 2012, Pages 909-917

  Kobayashi, Shin Ichiro ^a   Yokoyama, Yukihiro ^a   Matsushita, Tadashi ^b   Kainuma, Motoshi ^a   Ebata, Tomoki ^a   Igami, Tsuyoshi ^a   Sugawara, Gen ^a   Takahashi, Yu ^a   Nagino, Masato ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; PROTHROMBIN; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD ANALYSIS; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; JAPAN; LIVER RESECTION; MALE; OPERATION DURATION; PANCREATICODUODENECTOMY; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; THROMBOCYTE COUNT; THROMBOSIS; TIME;

ADAM PROTEINS; AGED; BIOLOGICAL MARKERS; FEMALE; HEPATECTOMY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 84867637613     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2012.998     Document Type: Article

References (27)

1. Thomas RM, Ahmad SA. Management of acute post-operative portal venous thrombosis. J Gastrointest Surg. 2010;14(3):570-577.
2. Mukherjee D, Lidor AO, Chu KM, Gearhart SL, Haut ER, Chang DC. Postoperative venous thromboembolism rates vary significantly after different types of major abdominal operations. J Gastrointest Surg. 2008;12(11):2015-2022.
3. Bagot CN, Arya R. Virchow and his triad: a question of attribution. Br J Haematol. 2008;143(2):180-190.
4. Denis CV, Wagner DD. Platelet adhesion receptors and their ligands in mouse models of thrombosis. Arterioscler Thromb Vasc Biol. 2007;27(4):728-739. (Pubitemid 46606699)
5. Ruggeri ZM. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost. 2003;1(7):1335-1342.
6. Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002;347(8):589-600.
7. Fujimura Y, Matsumoto M, Yagi H, Yoshioka A, Matsui T, Titani K. Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome. Int J Hematol. 2002;75(1):25-34. (Pubitemid 43014034)
8. Fujikawa K, Suzuki H, McMullen B, Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood. 2001;98(6):1662-1666.
9. Gerritsen HE, Robles R, Lämmle B, FurlanM. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood. 2001;98(6):1654-1661.
10. UemuraM, Fujimura Y, Ko S, MatsumotoM, Nakajima Y, Fukui H. Pivotal role of ADAMTS13 function in liver diseases. Int J Hematol. 2010;91(1):20-29.
11. Pereboom IT, Adelmeijer J, van Leeuwen Y, Hendriks HG, Porte RJ, Lisman T. Development of a severe von Willebrand factor/ADAMTS13 dysbalance during orthotopic liver transplantation. Am J Transplant. 2009;9(5):1189-1196.
12. Matsukawa M, Kaikita K, Soejima K, et al. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction. Am J Cardiol. 2007;100(5):758-763. (Pubitemid 47268262)
13. Zhao BQ, Chauhan AK, Canault M, et al. von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke. Blood. 2009;114(15):3329-3334.
14. Kobayashi T, Wada H, Nishioka N, et al. ADAMTS13 related markers and von Willebrand factor in plasma from patients with thrombotic microangiopathy (TMA). Thromb Res. 2008;121(6):849-854. (Pubitemid 351491286)
15. Kobayashi T, Wada H, Usui M, et al. Decreased ADAMTS13 levels in patients after living donor liver transplantation. Thromb Res. 2009;124(5):541-545.
16. Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med. 1998;339(22):1578-1584. (Pubitemid 28536132)
17. Mannucci PM, Vanoli M, Forza I, Canciani MT, Scorza R. Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis). Haematologica. 2003;88(8):914-918. (Pubitemid 37128091)
18. Matsuyama T, Uemura M, Ishikawa M, et al. Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis. Alcohol Clin Exp Res. 2007;31(1)(suppl):S27-S35.
19. Mannucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood. 2001;98(9):2730-2735.
20. Okano E, Ko S, Kanehiro H, Matsumoto M, Fujimura Y, Nakajima Y. ADAMTS13 activity decreases after hepatectomy, reflecting a postoperative liver dysfunction. Hepatogastroenterology. 2010;57(98):316-320.
21. Kamiya S, Nagino M, Kanazawa H, et al. The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity, and microflora. Ann Surg. 2004;239(4):510-517. (Pubitemid 38372767)
22. Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243(3):364-372. (Pubitemid 43327769)
23. Nagino M, Kamiya J, Kanai M, et al. Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility. Surgery. 2000;127(2):155-160. (Pubitemid 30091261)
24. Nagino M, Nimura Y, Nishio H, et al. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg. 2010;252(1):115-123.
25. Uemura M, Tatsumi K, Matsumoto M, et al. Localization of ADAMTS13 to the stellate cells of human liver. Blood. 2005;106(3):922-924. (Pubitemid 41076434)
26. Hori T, Kaido T, Oike F, et al. Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan. World J Gastroenterol. 2011;17(14):1848-1857.
27. Collins R, Peto R, Baigent C, Sleight P. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med . 1997;336(12):847-860. (Pubitemid 27132984)